Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Frontiers in Immunology
|
June 29, 2026
HLA-G expression in non-small cell lung cancer: prognostic significance and interplay with PD-L1 and CD8<sup>+</sup> tumor-infiltrating lymphocytes
Giulia Querzoli, Giuseppe Bogina, Marcella Marconi, et al.
The Laryngoscope
|
April 16, 2025
Effect of Serial Intralesional Steroid Injections on Risk of Recurrence in Idiopathic Subglottic Stenosis
Shengjie Ying, Peter Y F Zeng, Kevin Fung, et al.
Cell Stem Cell
|
December 4, 2014
Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis
Michael S Kareta, Laura L Gorges, Sana Hafeez, et al.
Cell Reports. Medicine
|
May 16, 2026
Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancer
Peter Y F Zeng, Jalna Meens, Amir Hossein Karimi, et al.
The Laryngoscope
|
May 6, 2025
Transcriptomic Features of Recurrence Rates in Idiopathic Subglottic Stenosis
Shengjie Ying, Peter Y F Zeng, Kevin Fung, et al.
Archives of Pathology & Laboratory Medicine
|
January 20, 2024
Assessment of Pathology Domain-Specific Knowledge of ChatGPT and Comparison to Human Performance
Andrew Y Wang, Sherman Lin, Christopher Tran, et al.
Ebiomedicine
|
March 6, 2025
Cohort-level clinical trajectory and molecular landscape of idiopathic subglottic stenosis for precision laryngology-a study of the Canadian Airways Research (CARE) group
R Jun Lin, Peter Y F Zeng, Kevin Fung, et al.
Ebiomedicine
|
March 6, 2025
Cellular blueprint of healthy and diseased human epiglottis and subglottis-a study of the Canadian Airways Research (CARE) group
Peter Y F Zeng, R Jun Lin, Kevin Fung, et al.
Cancer
|
May 24, 2023
Stereotactic ablative radiotherapy before resection to avoid delay for early-stage lung cancer or oligometastases during the COVID-19 pandemic: Pathologic outcomes from the SABR-BRIDGE protocol
Biniam Kidane, Ian J Gerard, Jonathan Spicer, et al.
Ebiomedicine
|
November 28, 2022
Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification
Peter Y F Zeng, Matthew J Cecchini, John W Barrett, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Frontiers in Immunology
|
June 29, 2026
HLA-G expression in non-small cell lung cancer: prognostic significance and interplay with PD-L1 and CD8<sup>+</sup> tumor-infiltrating lymphocytes
Giulia Querzoli, Giuseppe Bogina, Marcella Marconi, et al.
The Laryngoscope
|
April 16, 2025
Effect of Serial Intralesional Steroid Injections on Risk of Recurrence in Idiopathic Subglottic Stenosis
Shengjie Ying, Peter Y F Zeng, Kevin Fung, et al.
Cell Stem Cell
|
December 4, 2014
Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis
Michael S Kareta, Laura L Gorges, Sana Hafeez, et al.
Cell Reports. Medicine
|
May 16, 2026
Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancer
Peter Y F Zeng, Jalna Meens, Amir Hossein Karimi, et al.
The Laryngoscope
|
May 6, 2025
Transcriptomic Features of Recurrence Rates in Idiopathic Subglottic Stenosis
Shengjie Ying, Peter Y F Zeng, Kevin Fung, et al.
Archives of Pathology & Laboratory Medicine
|
January 20, 2024
Assessment of Pathology Domain-Specific Knowledge of ChatGPT and Comparison to Human Performance
Andrew Y Wang, Sherman Lin, Christopher Tran, et al.
Ebiomedicine
|
March 6, 2025
Cohort-level clinical trajectory and molecular landscape of idiopathic subglottic stenosis for precision laryngology-a study of the Canadian Airways Research (CARE) group
R Jun Lin, Peter Y F Zeng, Kevin Fung, et al.
Ebiomedicine
|
March 6, 2025
Cellular blueprint of healthy and diseased human epiglottis and subglottis-a study of the Canadian Airways Research (CARE) group
Peter Y F Zeng, R Jun Lin, Kevin Fung, et al.
Cancer
|
May 24, 2023
Stereotactic ablative radiotherapy before resection to avoid delay for early-stage lung cancer or oligometastases during the COVID-19 pandemic: Pathologic outcomes from the SABR-BRIDGE protocol
Biniam Kidane, Ian J Gerard, Jonathan Spicer, et al.
Ebiomedicine
|
November 28, 2022
Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification
Peter Y F Zeng, Matthew J Cecchini, John W Barrett, et al.
Page
of 8